Clinical Trial Update: Long-Term Follow-up of Patients Treated With Miltenyi Cell and Gene Therapies [NA]

View source ↗

Summary

Clinical trial update for Miltenyi Biomedicine's cell and gene therapy program indicates ongoing recruitment and planned long-term follow-up across multiple ind…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• B-cell Non-hodgkin Lymphoma
• Childhood Non-hodgkin Lymphoma
• Chronic Lymphocytic Leukemia
• Melanoma

Drugs mentioned

• Miltenyi Cell and Gene Therapies

Snippet

Sponsor: Miltenyi Biomedicine GmbH | Conditions: Melanoma Stage III, B-cell Non Hodgkin Lymphoma | NA | Status: RECRUITING